Sorry, you need to enable JavaScript to visit this website.

The Advanced Photon Source
a U.S. Department of Energy Office of Science User Facility

Another discovery by users of the Advanced Photon Source

Under Pressure, “Squishy” Compound Reacts in Remarkable Ways:  From insulator to metal and back again—a new transition phenomenon has been reported by scientists using the U.S. Department of Energy’s Advanced Photon Source.

Boosting the Performance of a Lower-Cost Fuel Cell Catalyst:  The findings from these studies, carried out at the U.S. Department of Energy’s Advanced Photon Source and Oak Ridge National Laboratory, along with fuel cell performance and durability data, supports cobalt-based catalysts as potential game-changers in the race to establish fuel cells as a sustainable energy solution.

A technology breakthrough at the Advanced Photon Source

New Form of Silicon Could Enable Next-Gen Electronic and Energy Devices:  Hexagonal forms of silicon have been synthesized previously, but only through the deposition of thin films or as nanocrystals that coexist with disordered material. In work based in large part on research carried out at the U.S. Department of Energy’s Advanced Photon Source, researchers report a synthesis pathway that produces the first high-quality, bulk crystals that serve as the basis for future research activities.

Advanced Photon Source Research with Positive Impacts on Our Health

A Template for Inhibiting SARS-CoV-2 Replication:  Researchers using the U.S. Department of Energy’s Advanced Photon Source determined crystal structures that will help guide the development of small-molecule drugs designed to stop the spread of COVID-19.

Another discovery by users of the Advanced Photon Source

Proteins of a Feather Come Together to Create Color:  Biologists would like to understand how and why birds are brightly colored. Some materials scientists look to nature to find better ways to recreate such colors. A study conducted using the U.S. Department of Energy’s Advanced Photon Source points to possible answers to both those questions and represents the first directly self-assembled single gyroid crystals known to science, potentially opening new photonic technologies.

Advanced Photon Source Research with Positive Impacts on Our Health

Engineering New Treatments for Cancer:  Trametinib, one example of a class of drugs known as MEK inhibitors, is a drug used to treat specific forms of skin and lung cancer and may be useful for treating several other forms of disease. A study carried out at three U.S. Department of Energy x-ray light sources, including the Advanced Photon Source, solved a trametinib mystery and may pave the way for a new generation of cancer drugs.

A Riddle Solved by Research at the Advanced Photon Source

Better-Educated Neural Networks for Nanoscale 3-D Coherent X-ray Imaging:  One of the inescapable realities of various imaging techniques is called the phase problem: the loss of phase information in imaging methods such as x-ray diffraction. Researchers working at the U.S. Department of Energy’s Advanced Photon Source have demonstrated a new approach to this perennial obstacle: a deep-learning neural network with enhanced accuracy to perform fast 3-D nanoscale imaging from coherent x-ray data.

Advanced Photon Source Research with Positive Impacts on Our Health

Mouse Brain Imaged from the Microscopic to the Macroscopic Level:  Researchers at the University of Chicago and the U.S. Department of Energy’s National Laboratory imaged an entire mouse brain across five orders of magnitude of resolution, allowing scientists to better connect existing imaging approaches and uncover new details about the structure of the brain.

Ultrafast X-rays Track Charge Flows in a Promising Photovoltaic Material:  A class of materials known as lead halide perovskites show remarkable potential for use in optoelectronic applications. Experiments carried out at the U.S. Department of Energy’s Advanced Photon Source should improve the theoretical framework used to describe these materials, thereby hastening their practical use for solar power and other applications.

Advanced Photon Source Research with Positive Impacts on Our Health

Escape Artist:  Research at the U.S. Department of Energy’s Advanced Photon Source sheds light on the ways in which compromised immunity may render SARS-CoV-2 fitter and capable of evading the immune system.

Advanced Photon Source Research with Positive Impacts on Our Health

Using Protein Structural Information to Understand the Mechanism of an Essential Enzyme for Fighting Tuberculosis:  Antibiotic resistance is a global problem that many scientists are racing to solve. Researchers using the APS gained important insights into understanding the structure and mechanism of a critical enzyme involved in protein synthesis in tuberculosis, work that will form the basis of structure-based drug design efforts aimed at exploiting the unique features of this enzyme in developing new pharmaceuticals.

FROM THE APS DIRECTOR

UPDATE 7/29/21: Based on the most recent CDC guidance, all individuals regardless of vaccination status are required to wear masks while on site. Face coverings must be worn in all public and work areas within a building (e.g., shared offices and labs, hallways, elevators, restrooms). Face coverings are required in all face-to-face meetings and at security checkpoints (though security may ask you to lower your face covering to verify identity). Face coverings are also required inside government-owned vehicles when another person is in the vehicle. Face coverings may be removed when alone in an enclosed space or when necessary to eat, provided you are six feet away from other people. Face coverings are required outdoors only when you are within six feet of another person.

All employees and APS users must maintain a minimum of six feet of distance from others while onsite.

Argonne and the APS remain in a state of limited operations. Mail-in/remote experiments continue, and on-site experimenter presence is permitted ONLY for experiments that have gone through a pre-approval process based on need for access. The number of users allowed on site also remains capped on a per-experiment basis.

External users should be prepared to show proof of vaccination.

Requests for onsite experiment access and any general questions concerning the policy above should be sent to apsuser@anl.gov

 

Conferences, Workshops, Meetings

Aug 01 2021 to Aug 04 2021

Aug 14 2021 to Aug 22 2021

Sep 06 2021 to Sep 09 2021

Sep 13 2021 to Sep 17 2021

Nov 01 2021 to Nov 02 2021

Nov 03 2021 to Nov 04 2021